Novo Nordisk’s future doubtful after Wegovy maker’s ‘shock’ CEO ouster



Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the way forward for the Wegovy weight problems drug maker.